3 terminated. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 3 |
| Phase 2 | 2 | Terminated 2 |
Follow COVID: new trials by email Literature Review of COVID trials Research Report on COVID
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation BM-Allo.MSC, Placebo - COVID | Phase 1 | Terminated | ImmunityBio, Inc. | 4 | 2020-08-03 | 2024-09-05 |
| hCT-MSCs for COVID19 ARDS Human cord tissue mesenchymal stromal cells (hCT-MSC) manufactured by Duke University., Placebo - COVID, Corona Virus Infection | Phase 1 / Phase 2 | Terminated | Joanne Kurtzberg, MD | 12 | 2020-06-18 | 2022-12-20 |
| Convalescent Plasma vs. Standard Plasma for COVID-19 Convalescent Plasma, Standard Donor Plasma - COVID | Phase 1 / Phase 2 | Terminated | Stony Brook University | 82 | 2020-04-08 | 2021-12-06 |
COVID-19 (2) · Coronavirus Infections (1) · Dyspnea (1) · Respiratory Distress Syndrome (1)
Coronaviridae Infections (2) · Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pneumonia (2) · Pneumonia, Viral (2) · RNA Virus Infections (2) · Respiration Disorders (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Virus Diseases (2) · Coronavirus Infections (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Signs and Symptoms, Respiratory (1)
ImmunityBio, Inc. (1) · Joanne Kurtzberg, MD (1) · Stony Brook University (1)
United States (3)
Elliott Bennett-Guerrero, MD (1) · Joanne Kurtzberg, MD (1) · Lingye Chen, MD (1)